Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Solowin Holdings Sells 1M Class B Shares to CEO-Linked Buyer

Solowin Holdings filed a Form 6-K on November 5, 2026, disclosing that it entered into a securities purchase agreement on that date to sell 1,000,000 Class B ordinary shares to Gemini Asia Holdings Limited, an entity ultimately beneficially owned by the company's Chairman and …

Vinay Lochav | 06 November 2026

Invesco CurrencyShares Swiss Franc Trust Q3 2026: 3,550,000 Shares Outstanding

Invesco CurrencyShares Swiss Franc Trust filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the period ended September 30, 2026, and reporting total assets of $374,628,810 held primarily as interest-bearing Swiss Franc deposits.

Aakashdeep | 06 November 2026

Allogene Therapeutics Q3 2026: $50.4M Net Loss, Share Count Rises

Allogene Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing a net loss of $50.369 million for the three months ended September 30, 2026.

Vinay Lochav | 06 November 2026

Solowin Holdings Sells 10.3M Shares at $1.20 in Direct Offering

Solowin Holdings filed a Form 6-K with the SEC on November 5, 2026, disclosing a registered direct offering of 10,300,000 Class A ordinary shares at $1.20 per share to certain individual investors, with expected gross proceeds of approximately $12,360,000.

Aditi Sarkar | 06 November 2026

QIAGEN Files 6-K for Q3 2026 Earnings Press Release

QIAGEN N.V. filed a Form 6-K with the SEC on November 5, 2026, furnishing a press release that announced unaudited financial results for the third quarter ended September 30, 2026.

Manish Choudhary | 06 November 2026

Invesco CurrencyShares Euro Trust Q3 2026: 3,150,000 Shares

Invesco CurrencyShares Euro Trust filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing financial condition and results of operations for the three and nine months ended on that date.

Anjali Anand | 06 November 2026

10x Genomics Q3 2026: $526M Cash, 121M Shares Outstanding

10x Genomics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting condensed consolidated balance sheet figures and share counts as of that date.

Aakashdeep | 06 November 2026

Gran Tierra Energy Files Q3 2026 Results 8-K on Nov 5

Gran Tierra Energy Inc. filed a Form 8-K on November 6, 2026, reporting that on November 5, 2026, it issued a press release announcing its financial and operating results for the quarter ended September 30, 2026.

Vinay Lochav | 06 November 2026

Pershing Square Inc. Files Q3 2026 10-Q With 400M Shares Outstanding

Pershing Square Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 6, 2026, disclosing 400,000,000 shares of common stock outstanding as of October 30, 2026.

Vinay Lochav | 06 November 2026

Avnet Q1 FY2027: Sales Jump to $10.7B, Net Income $282M

Avnet, Inc. filed its Form 10-Q for the first fiscal quarter ended October 3, 2026, with the SEC on November 6, 2026, reporting quarterly sales of $10,717,980 thousand and net income of $282,172 thousand.

Aditi Sarkar | 06 November 2026
Support

Hi! How can we help you today?

Loading…